Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1200 participants
OBSERVATIONAL
2024-05-21
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participant of the study
Adolescents at 13- 15 years of age, currently studying in MOE-registered secondary school in Singapore and part of the DREAMS cohort.
No intervention
No intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Currently studying in MOE registered school
3. Part of the DREAMS study
Exclusion Criteria
2. Not part of the DREAMS study
13 Years
15 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Education
UNKNOWN
Nanyang Technological University
OTHER
Institute of High Performance Computing (IHPC), A*STAR Research Institutes
UNKNOWN
Institute for Human Development and Potential (IHDP), Singapore
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Johan Eriksson
Executive Director, Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
A*STAR Institute for Human Development and Potential (IHDP)
Singapore, Singapore, Singapore
Singapore Institute of Clinical Sciences
Singapore, , Singapore
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Janet Lim, BS
Role: primary
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form: IADORE SUB-STUDY BIOSAMPLE ICF_V1 dated 10Dec2024
Document Type: Informed Consent Form: IADORE SUB-STUDY BIOSAMPLE ICF
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-1200
Identifier Type: -
Identifier Source: org_study_id